Literature DB >> 24679869

Cystatin C as a marker of early renal insufficiency in children with congenital neuropathic bladder.

Janelle A Fox1, Anne G Dudley2, Carlton Bates3, Glenn M Cannon4.   

Abstract

PURPOSE: Due to decreased muscle mass in children with congenital neuropathic bladder there may be significant inaccuracy when using the creatinine based estimated glomerular filtration rate. Cystatin C is highly sensitive and specific for measuring changes in the glomerular filtration rate in children and in patients with muscle wasting conditions. We hypothesized that a cystatin C calculated glomerular filtration rate would be more sensitive than the standard creatinine based modified Schwartz equation to detect renal insufficiency in children with congenital neuropathic bladder.
MATERIALS AND METHODS: We prospectively identified children with congenital neuropathic bladder at a multidisciplinary spina bifida clinic who underwent serum creatinine and serum cystatin C testing. Clinical history and anthropomorphic variables at the time of laboratory testing were catalogued. The creatinine based glomerular filtration rate was estimated using the modified (bedside) Schwartz formula and the cystatin C based rate was calculated using the Zappitelli cystatin C formula.
RESULTS: Dual estimated glomerular filtration rate calculation was done in 69 children at a total of 74 patient encounters. Absolute creatinine was within age range normal limits in each patient, including 1 with chronic kidney disease stage 3A. The median creatinine based estimated glomerular filtration rate was 123 ml per minute/1.73 m(2) (range 58 to 229). The median cystatin C based estimated rate was 103 ml per minute/1.73 m(2) (range 47 to 144) for an absolute median rate reduction of 15.4%. Using cystatin C estimates chronic kidney disease stage was upgraded from stage 1 to 2 in 13 patients (18.8%).
CONCLUSIONS: In children with neuropathic bladder the cystatin C estimated glomerular filtration rate is a better screening test for early renal insufficiency that is not detected by creatinine based rate calculations. To our knowledge it remains to be determined whether the cystatin C estimated glomerular filtration rate can ultimately improve the clinical outcome in this population.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  creatinine; cystatin C; glomerular filtration rate; kidney; neurogenic; urinary bladder

Mesh:

Substances:

Year:  2014        PMID: 24679869     DOI: 10.1016/j.juro.2013.09.093

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Estimated kidney function in children and young adults with spina bifida: A retrospective cohort study.

Authors:  David I Chu; Lauren C Balmert; Cameron M Arkin; Theresa Meyer; Ilina Rosoklija; Belinda Li; Kavita S Hodgkins; Susan L Furth; Earl Y Cheng; Elizabeth B Yerkes; Tamara Isakova
Journal:  Neurourol Urodyn       Date:  2019-07-08       Impact factor: 2.696

Review 2.  Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery.

Authors:  Marianne Schmid; Deepansh Dalela; Rana Tahbaz; Jessica Langetepe; Marco Randazzo; Roland Dahlem; Margit Fisch; Quoc-Dien Trinh; Felix K-H Chun
Journal:  World J Nephrol       Date:  2015-05-06

Review 3.  Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury.

Authors:  Mikolaj Przydacz; Piotr Chlosta; Jacques Corcos
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

4.  Chronic kidney disease and upper tract concerns after congenital and acquired urinary tract abnormalities: considerations for transition of care in teens and young adults.

Authors:  Elizabeth B Yerkes; Michelle Baum; David I Chu
Journal:  World J Urol       Date:  2020-06-08       Impact factor: 4.226

5.  Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida.

Authors:  Jonathan C Routh; Earl Y Cheng; J Christopher Austin; Michelle A Baum; Patricio C Gargollo; Richard W Grady; Adrienne R Herron; Steven S Kim; Shelly J King; Chester J Koh; Pangaja Paramsothy; Lisa Raman; Michael S Schechter; Kathryn A Smith; Stacy T Tanaka; Judy K Thibadeau; William O Walker; M Chad Wallis; John S Wiener; David B Joseph
Journal:  J Urol       Date:  2016-07-27       Impact factor: 7.450

Review 6.  Congenital causes of neurogenic bladder and the transition to adult care.

Authors:  Christopher J Loftus; Hadley M Wood
Journal:  Transl Androl Urol       Date:  2016-02

7.  Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity.

Authors:  Stacey Tannenbaum; Martin den Adel; Walter Krauwinkel; John Meijer; Adriana Hollestein-Havelaar; Frank Verheggen; Donald Newgreen
Journal:  Pharmacol Res Perspect       Date:  2020-12

8.  Evaluation and management of neurogenic bladder after spinal cord injury: Current practice among physical medicine and rehabilitation specialists in Turkey.

Authors:  Yeşim Akkoç; Murat Ersöz; Ece Çınar; Haydar Gök
Journal:  Turk J Phys Med Rehabil       Date:  2021-05-25

9.  Are Tubular Injury Markers NGAL and KIM-1 Useful in Pediatric Neurogenic Bladder?

Authors:  Joanna Bagińska; Agata Korzeniecka-Kozerska
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

10.  Plastic Antibody of Polypyrrole/Multiwall Carbon Nanotubes on Screen-Printed Electrodes for Cystatin C Detection.

Authors:  Rui S Gomes; Blanca Azucena Gomez-Rodríguez; Ruben Fernandes; M Goreti F Sales; Felismina T C Moreira; Rosa F Dutra
Journal:  Biosensors (Basel)       Date:  2021-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.